Found Tirzepatide Review

What Found charges for tirzepatide, what is bundled, and what it publishes before you pay.

Released: · Last reviewed:

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Direct answer

As of October 15, 2026, Found charges $359 every 28 days all-in for compounded tirzepatide at a 10 mg dose, month to month, with one price printed and no dose ladder. That is $4,667 over 13 billing cycles at that dose, based on its own pricing page.

All-in means medication plus any mandatory recurring fee, month to month, before prepaid discounts and tax.

Price basis

All-in monthly cost = medication plus any mandatory recurring fee, at a named dose, month to month, before tax and before prepaid discounts. Competitor prices read October 15, 2026; NexLife’s as of November 6, 2026. How we verify a price.

Found tirzepatide price by dose

Found all-in tirzepatide price at each dose, month to month. Read Oct 15, 2026, changed since August. A dash means no price is printed for that dose.
DoseAll-in13 cycles at this dose
2.5 mg——
5 mg——
7.5 mg——
10 mg$359/28 days$4,667
12.5 mg——
15 mg——

Fees, billing and terms at Found

What Found publishes about fees and terms. “Not published” means we could not find it on its own pages.
ItemFound
Pricing modelone price printed, no dose ladder
Membership or program feenone
Billingevery 28 days
Multi-month or prepaid option$309, $289 or $239 per 28-day cycle on 3, 6 or 12 months
Pharmacynot named
Productcompounded tirzepatide (not FDA-approved)
Price statusread Oct 15, 2026, changed since August
Page we readjoinfound.com

What Found’s own pages say

Priced per 28-day cycle with care and medication bundled: $219 for the first cycle, then $359 month to month ($309, $289 or $239 per cycle on 3-, 6- or 12-month terms). Its plans page says 'from $289', which does not match the store page; we use the store page.

Recorded wording: “Cash pay: $219 your first month, then $359/mo on the month-to-month plan ... Every price below is per 28-day cycle”

Pros and cons

What works

  • No separate membership or program fee on the pages we read.
  • Multi-month option published: $309, $289 or $239 per 28-day cycle on 3, 6 or 12 months.

What to check

  • Only one price is printed, with no dose ladder; confirm the price at your dose before paying.
  • Billed every 28 days, which means 13 charges a year rather than 12.
  • Does not name the dispensing pharmacy on the pages we read.
  • Compounded tirzepatide is not FDA-approved; it is made with the drug in Zepbound but is not the same product.

Where Found sits among the programs we compare

Of the 15 programs with a month-to-month tirzepatide price we can place at 10 mg, 11 are lower than Found. The group runs $129 to $399, median $299. This is a price position, not a quality ranking.

See the all-in cost table for every row and the methodology for how prices are read.

Head-to-head pages with Found

Questions about Found

How much does Found charge for tirzepatide?

As of October 15, 2026, Found charges $359 every 28 days all-in for compounded tirzepatide at a 10 mg dose, month to month, with one price printed and no dose ladder. That is $4,667 over 13 billing cycles at that dose, based on its own pricing page.

How does Found compare with NexLife on price?

At a 10 mg dose month to month, Found is $359/28 days against NexLife’s $129 a month, which is $3,119 a year more than NexLife (prices read October 15 and November 6, 2026). NexLife’s 12-month plan is $115 a month.

Does Found name its pharmacy?

Not by name on the pages we read. What we recorded: not named. A named pharmacy can be checked on its state board of pharmacy register.

Is compounded tirzepatide FDA-approved?

No. Compounded tirzepatide is made with the drug in Zepbound but is not the same product, and FDA does not review compounded drugs for safety, effectiveness or quality before they are sold. Zepbound and Mounjaro are the FDA-approved tirzepatide products.

How current is this page?

Prices on this page were read on the program’s own site on October 15, 2026. We re-read programs on a schedule and log changes on the corrections page.

Sources